Depomed, Inc. Reports First Quarter 2013 Financial Results

Published: May 09, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

NEWARK, Calif., May 8, 2013 /PRNewswire/ -- Depomed, Inc. (DEPO) today reported financial results for the quarter ended March 31, 2013.

First Quarter 2013 Update

•Total revenues of $26.2 million, an increase of 55% over first quarter 2012

•Gralise® (gabapentin) net sales of $6.1 million

Help employers find you! Check out all the jobs and post your resume.

Back to news